American Society of Hirudotherapy

Hirudotherapy (medicinal leeches) for treatment of upper airway obstruction in a dog

Trenholme HN, Masseau I, Reinero CR (2021) · Journal of Veterinary Emergency and Critical Care · 1 patient

Case-level evidence: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Study record: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.
GRADE Very LowCase reportLeech therapy in other conditions

Study Profile

Design
single veterinary case report of medicinal leech therapy as ancillary treatment for upper airway obstruction caused by sublingual and cervical soft-tissue swelling in a Mastiff (University of Missouri College of Veterinary Medicine, USA; Université de Montréal, Canada)
Patient
1
Presentation and intervention
Application of Hirudo verbana medicinal leeches to sublingual and cervical regions of a 10-month-old female Mastiff intubated for upper airway obstruction from soft-tissue swelling; leeches applied as adjunct to standard supportive care
Outcome
Continued slow bleeding from leech detachment sites enabled gradual reduction of sublingual hematoma and resolution of airway obstruction; the dog was extubated at 44 hours after intubation and discharged from hospital; first veterinary case report of medicinal leeches (Hirudo verbana) as complementary treatment for sublingual hematoma contributing to upper airway obstruction
Follow-up duration
44 hours intubation period plus discharge

Key Findings

  • First reported use of medicinal leeches (Hirudo verbana) for sublingual hematoma in a dog
  • Successful extubation at 44 hours following leech therapy adjunct to standard airway management
  • Demonstrates that the venous-drainage mechanism of leech therapy is operative across species
  • Adds Hirudo verbana species data to the predominantly Hirudo medicinalis veterinary literature
  • Provides translational rationale for considering leech therapy in human sublingual hematoma airway compromise

Limitations

  • Single case (n=1) - cannot establish veterinary efficacy or safety profile
  • Veterinary species (Mastiff) - not directly applicable to human anatomy or coagulation profile
  • Concurrent multiple therapies (propofol/fentanyl infusion, supportive care) confound attribution to leech therapy
  • No randomized comparator or alternative treatment arm
  • Long-term outcomes not reported in abstract

Clinical Implications

Trenholme 2021 is a single veterinary case report extending hirudotherapy applicability to canine upper-airway obstruction from sublingual hematoma. For ASH editorial purposes, the trial provides cross-species mechanistic context supporting the venous-drainage rationale of leech therapy. For US clinicians, the report does not change practice but does illustrate that the basic mechanism translates across mammalian species. The veterinary case is included in the registry to document the breadth of the hirudotherapy evidence base, including its extension beyond standard human plastic-surgery indications.

Related studies

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.